GAINESVILLE, Fla. -- (Business Wire)
Inc. (Nasdaq: EXAC),
a developer and producer of bone and joint restoration products for hip,
knee, shoulder, spine and biologic materials will update investors and
analysts at the Piper Jaffray Healthcare Conference in New York on
Tuesday, November 27, 2012.
The presentation session by Exactech president David Petty and CFO Jody
Phillips will begin at 11:30 a.m. ET on November 27, and will include a
question and answer session. The company will also host one-on-one
meetings with investors during the conference.
An audio replay of Exactech’s conference session as well as the
company’s presentation slides will be available at http://www.hawkassociates.com/profile/exac.cfm
Based in Gainesville, Fla., Exactech develops and markets orthopaedic
implant devices, related surgical instruments and biologic materials and
services to hospitals and physicians. The company manufactures many of
its orthopaedic devices at its Gainesville facility. Exactech’s
orthopaedic products are used in the restoration of bones and joints
that have deteriorated as a result of injury or diseases such as
arthritis. Exactech markets its products in the United States, in
addition to more than 30 markets in Europe, Latin America, Asia and the
Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com.
Copies of Exactech’s press releases, SEC filings, current price quotes
and other valuable information for investors may be found at http://www.exac.com
An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm.
To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities Exchange Act of 1934, which represent the company’s
expectations or beliefs concerning future events of the company’s
financial performance. These forward-looking statements are further
qualified by important factors that could cause actual results to differ
materially from those in the forward-looking statements. These factors
include the effect of competitive pricing, the company’s dependence on
the ability of third party manufacturers to produce components on a
basis which is cost-effective to the company, market acceptance of the
company’s products and the effects of government regulation. Results
actually achieved may differ materially from expected results included
in these statements.
Jody Phillips, 352-377-1140
Julie Marshall or Frank
Source: Exactech Inc.
© 2018 Canjex Publishing Ltd. All rights reserved.